MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NephroGenex Company Profile (NASDAQ:NRX)

Consensus Ratings for NephroGenex (NASDAQ:NRX) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $14.50 (10,249.75% upside)

Analysts' Ratings History for NephroGenex (NASDAQ:NRX)
Show:
DateFirmActionRatingPrice TargetActions
4/15/2016Rodman & RenshawReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016HC WainwrightDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015MLV & Co.Reiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/31/2014AegisReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha